Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial - PubMed (original) (raw)
Randomized Controlled Trial
. 2019 Feb;58(1):345-356.
doi: 10.1007/s00394-017-1598-5. Epub 2017 Dec 18.
Affiliations
- PMID: 29255930
- DOI: 10.1007/s00394-017-1598-5
Randomized Controlled Trial
Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial
Fei Ma et al. Eur J Nutr. 2019 Feb.
Abstract
Purpose: Observational studies have frequently reported that low blood folate concentrations are associated with poor cognitive performance. Our previous studies have shown the potential beneficial effect on the metabolite levels of methionine cycle and peripheral blood inflammatory cytokines from 6- and 12-month folic acid supplementation on cognitive function in mild cognitive impairment (MCI). This study aims to continue exploring the effect of 24-month folic acid supplementation on cognitive function and pathological mechanism in MCI.
Methods: 180 individuals with MCI were identified and randomly divided into intervention (folic acid 400 µg/day, n = 90) and convention (n = 90) groups. Cognitive function (WAIS-RC) and blood Aβ-related biomarkers were measured at baseline and at 6, 12, 18, and 24 months. Data were analyzed using generalized estimating equation. This trial has been registered with Trial Number: ChiCTR-TRC-13003227.
Results: During the follow-up, scores of full scale IQ, verbal IQ, and subdomains of Information and Digit Span were significantly higher in the intervention group than those in the convention group (P < 0.05). In the intervention group, blood homocysteine, S-adenosylhomocysteine (SAH), Aβ-42, and the expression of APP-mRNA were decreased (P < 0.05), while S-adenosylmethionine (SAM), SAM/SAH ratio, and the expression of DNA methyltransferase mRNA were increased (P < 0.05).
Conclusion: Folic acid supplementation appears to improve cognitive function and reduce blood levels of Aβ-related biomarkers in MCI. Larger-scale double-blind placebo-controlled randomized trials of longer duration are needed.
Keywords: Cognitive function; DNA methyltransferase; Folate; Mild cognitive impairment; Randomized controlled trial; β-Amyloid.
Similar articles
- Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial.
Bai D, Fan J, Li M, Dong C, Gao Y, Fu M, Huang G, Liu H. Bai D, et al. J Alzheimers Dis. 2021;81(1):155-167. doi: 10.3233/JAD-200997. J Alzheimers Dis. 2021. PMID: 33749643 Retracted. Clinical Trial. - Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China.
Ma F, Wu T, Zhao J, Han F, Marseglia A, Liu H, Huang G. Ma F, et al. J Gerontol A Biol Sci Med Sci. 2016 Oct;71(10):1376-83. doi: 10.1093/gerona/glv183. Epub 2015 Oct 27. J Gerontol A Biol Sci Med Sci. 2016. PMID: 26508298 Clinical Trial. - Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design.
Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G. Ma F, et al. Curr Alzheimer Res. 2019;16(7):622-632. doi: 10.2174/1567205016666190725144629. Curr Alzheimer Res. 2019. PMID: 31345146 Clinical Trial. - Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M, Grimley EJ, Areosa SA. Malouf M, et al. Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. PMID: 14584018 Updated. Review. - Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
Malouf R, Grimley Evans J. Malouf R, et al. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843658 Review.
Cited by
- Blood metabolites, neurocognition and psychiatric disorders: a Mendelian randomization analysis to investigate causal pathways.
Guo J, Yang P, Wang JH, Tang SH, Han JZ, Yao S, Yu K, Liu CC, Dong SS, Zhang K, Duan YY, Yang TL, Guo Y. Guo J, et al. Transl Psychiatry. 2024 Sep 16;14(1):376. doi: 10.1038/s41398-024-03095-4. Transl Psychiatry. 2024. PMID: 39285197 Free PMC article. - Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration.
Sobral AF, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa DJ. Sobral AF, et al. Int J Mol Sci. 2024 Aug 28;25(17):9339. doi: 10.3390/ijms25179339. Int J Mol Sci. 2024. PMID: 39273288 Free PMC article. Review. - Mendelian randomization to evaluate the effect of folic acid supplement on the risk of Alzheimer disease.
Sun X, He C, Yang S, Li W, Qu H. Sun X, et al. Medicine (Baltimore). 2024 Feb 9;103(6):e37021. doi: 10.1097/MD.0000000000037021. Medicine (Baltimore). 2024. PMID: 38335403 Free PMC article. - Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials.
Chang J, Liu M, Liu C, Zhou S, Jiao Y, Sun H, Ji Y. Chang J, et al. Eur J Nutr. 2024 Jun;63(4):1003-1022. doi: 10.1007/s00394-024-03324-y. Epub 2024 Feb 1. Eur J Nutr. 2024. PMID: 38300291 Free PMC article.
References
- J Aging Health. 1993 May;5(2):179-93 - PubMed
- Nature. 1999 Jun 24;399(6738 Suppl):A23-31 - PubMed
- N Engl J Med. 1999 Nov 11;341(20):1485-90 - PubMed
- Arch Neurol. 2000 Jan;57(1):100-5 - PubMed
- Neurology. 2001 May 8;56(9):1133-42 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 15ZCZDSY01040/Tianjin Science and Technology Support Program
- 81130053/the National Natural Science Foundation of China
- 2016KJ0304/Tianjin 13th five plan and TMU talent project
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical